LaChapelle Robin

CIK 00020091361 companyNEWTOWN SQUARE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0002009136

Recent Transactions

18 trades

Award
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2026-02-02+130,000→ 130,000 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2025-07-11−2,600→ 12,873 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2025-07-11−2,050→ 410 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2025-07-11$2.28/sh+2,050→ 126,633 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2025-07-11−6,503→ 6,370 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2025-07-11$2.28/sh+6,503→ 135,736 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2025-07-11$2.28/sh+2,600→ 129,233 total
Award
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2025-02-03+120,000→ 120,000 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-09-19−12,364→ 18,865 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2024-09-19$2.28/sh+2,471→ 112,219 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-09-19−2,700→ 56,471 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2024-09-19$2.28/sh+2,867→ 102,584 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-09-19−2,471→ 2,460 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2024-09-19$6.24/sh+2,700→ 99,717 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2024-09-19$2.28/sh+7,164→ 109,748 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Common Stock
2024-09-19$3.65/sh+12,364→ 124,583 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-09-19−2,867→ 22,637 total
Exercise/Conversion
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-09-19−7,164→ 15,473 total

Companies

ArriVent BioPharma, Inc.
Chief Operating Officer
$AVBP

Recent Filings

Address

C/O ARRIVENT BIOPHARMA, INC. 18 CAMPUS BOULEVARD, SUITE 100

NEWTOWN SQUARE, PA, 19073

View on SEC.gov